RxDoctor Payments Data

Eric Meshulam, DPM

Podiatrist · Muncie, INNPI 1720427040

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (42.0%), education and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Stryker at 43.4% of the total. Reporting peaked in 2019 at $3,729 and has fallen 90.0% since, to $373 in 2025.

$6,279in general payments, 2019–2025

Across 65 payments — averaging $96.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$3K
  • Wardlow Enterprises$2K
  • Biotissue Holdings Inc.$361
  • Zimmer Biomet$210
  • Integra Lifesciences Corporation$157
  • Organogenesis Inc.$131
  • plus $480 from 12 others

What the payments were for

  • Travel & lodging$1,31421%
  • Food & beverage$2,63642%
  • Education$2,21635%
  • Gifts$891%
  • Entertainment$250%

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,279 in reported general payments places this provider in the 80th percentile of 131 podiatrist providers in Indiana.

See all podiatrist providers in Indiana

Medicare billing

Part B allowed, 2024
$107,313
Medicare patients
516
Services billed
1,090

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole17$326
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen11$111

Paid to pharmacies, not to this prescriber.

Other podiatrist in Muncie

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →